Zobrazeno 1 - 10
of 4 562
pro vyhledávání: '"Fuks, F"'
Autor:
Marker, Paul C.
Publikováno v:
In Urologic Oncology: Seminars and Original Investigations 2007 25(3):279-280
Autor:
Fuks F; Laboratory of Cancer Epigenetics, ULB-Cancer Research Center, Université libre de Bruxelles (ULB), Faculty of Medicine, Route de Lennik 808, 1070 Brussels, Belgium; Jules Bordet Institute, Rue Meylemeersch 90, 1070 Brussels, Belgium. Electronic address: francois.Fuks@ulb.be., Kharas M; Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: kharasm@mskcc.org.
Publikováno v:
Current opinion in genetics & development [Curr Opin Genet Dev] 2024 Dec; Vol. 89, pp. 102271. Date of Electronic Publication: 2024 Oct 24.
Autor:
Yao Y; Department of Gastroenterology and Hepatology, the First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China., Lv H; Department of Gastroenterology and Hepatology, the First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.; Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, China., Zhang M; Department of Gastroenterology and Hepatology, the First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China., Li Y; Department of Gastroenterology and Hepatology, the First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.; Henan Institute of Advanced Technology, Zhengzhou University, Zhengzhou, 450001, China., Herman JG; UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA., Brock MV; Department of surgery, School of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, 21287, USA., Gao A; Department of Gastroenterology and Hepatology, the First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China., Wang Q; Department of Gastroenterology and Hepatology, the First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China., Fuks F; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Universite Libre de Bruxelles (ULB), Brussels, 1070, Belgium., Zhang L; Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, China. zhanglirongzzu@126.com., Guo M; Department of Gastroenterology and Hepatology, the First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China. mzguo@hotmail.com.; National Key Laboratory of Kidney Diseases, the First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China. mzguo@hotmail.com.
Publikováno v:
Frontiers of medicine [Front Med] 2024 Aug; Vol. 18 (4), pp. 721-734. Date of Electronic Publication: 2024 Jun 27.
Autor:
Pinello N; Faculty of Medicine and Health, The University of Sydney, Camperdown, 2050, Australia.; Epigenetics and RNA Biology Program Centenary Institute, The University of Sydney, Camperdown, 2050, Australia.; Functional Genomics Laboratory, Institut Pasteur de Montevideo, 11400, Montevideo, Uruguay., Song R; Faculty of Medicine and Health, The University of Sydney, Camperdown, 2050, Australia.; Epigenetics and RNA Biology Program Centenary Institute, The University of Sydney, Camperdown, 2050, Australia., Lee Q; Faculty of Medicine and Health, The University of Sydney, Camperdown, 2050, Australia.; Epigenetics and RNA Biology Program Centenary Institute, The University of Sydney, Camperdown, 2050, Australia., Calonne E; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB Cancer Research Center (U-CRC), Jules Bordet Institute, Université Libre de Bruxelles (ULB), Brussels, Belgium., Duan KL; The Molecular and Cell Biology Lab, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China., Wong E; Faculty of Medicine and Health, The University of Sydney, Camperdown, 2050, Australia.; Epigenetics and RNA Biology Program Centenary Institute, The University of Sydney, Camperdown, 2050, Australia., Tieng J; Faculty of Medicine and Health, The University of Sydney, Camperdown, 2050, Australia.; Epigenetics and RNA Biology Program Centenary Institute, The University of Sydney, Camperdown, 2050, Australia., Mehravar M; Faculty of Medicine and Health, The University of Sydney, Camperdown, 2050, Australia.; Epigenetics and RNA Biology Program Centenary Institute, The University of Sydney, Camperdown, 2050, Australia., Rong B; Shanghai Key Laboratory of Medical Epigenetics, International Co-Laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China., Lan F; Shanghai Key Laboratory of Medical Epigenetics, International Co-Laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China., Roediger B; Faculty of Medicine and Health, The University of Sydney, Camperdown, 2050, Australia.; Skin Inflammation Group, Centenary Institute, The University of Sydney, Camperdown, 2050, Australia.; Autoimmunity, Transplantation and Inflammation (ATI) Disease Area, Novartis Institutes for BioMedical Research, Basel, Switzerland., Ma CJ; School of Public Health, Wuhan University, Wuhan, 430071, China., Yuan BF; School of Public Health, Wuhan University, Wuhan, 430071, China., Rasko JEJ; Faculty of Medicine and Health, The University of Sydney, Camperdown, 2050, Australia.; Gene and Stem Cell Therapy Program, Centenary Institute, The University of Sydney, Camperdown, 2050, Australia.; Cell and Molecular Therapies, Royal Prince Alfred Hospital, Camperdown, 2050, NSW, Australia., Larance M; Faculty of Medicine and Health, The University of Sydney, Camperdown, 2050, Australia.; Charles Perkins Centre, School of Medical Sciences, University of Sydney, Sydney, 2006, Australia., Ye D; The Molecular and Cell Biology Lab, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China., Fuks F; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB Cancer Research Center (U-CRC), Jules Bordet Institute, Université Libre de Bruxelles (ULB), Brussels, Belgium., Wong JJ; Faculty of Medicine and Health, The University of Sydney, Camperdown, 2050, Australia. justin.wong@sydney.edu.au.; Epigenetics and RNA Biology Program Centenary Institute, The University of Sydney, Camperdown, 2050, Australia. justin.wong@sydney.edu.au.; Charles Perkins Centre, School of Medical Sciences, University of Sydney, Sydney, 2006, Australia. justin.wong@sydney.edu.au.
Publikováno v:
Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2024 May 23; Vol. 81 (1), pp. 229. Date of Electronic Publication: 2024 May 23.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Singh BN; Waksman Institute, Rutgers University, Piscataway, New Jersey, United States of America., Tran H; Waksman Institute, Rutgers University, Piscataway, New Jersey, United States of America., Kramer J; Department of Pathology and Laboratory Medicine, Rutgers Biomedical and Health Sciences, Rutgers University, New Brunswick, New Jersey, United States of America., Kirichenko E; Waksman Institute, Rutgers University, Piscataway, New Jersey, United States of America., Changela N; Waksman Institute, Rutgers University, Piscataway, New Jersey, United States of America., Wang F; Waksman Institute, Rutgers University, Piscataway, New Jersey, United States of America., Feng Y; Waksman Institute, Rutgers University, Piscataway, New Jersey, United States of America., Kumar D; Waksman Institute, Rutgers University, Piscataway, New Jersey, United States of America., Tu M; Waksman Institute, Rutgers University, Piscataway, New Jersey, United States of America., Lan J; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Bizet M; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Fuks F; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Steward R; Waksman Institute, Rutgers University, Piscataway, New Jersey, United States of America.; Department of Molecular Biology and Biochemistry, Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey, United States of America.
Publikováno v:
PloS one [PLoS One] 2024 Feb 21; Vol. 19 (2), pp. e0293894. Date of Electronic Publication: 2024 Feb 21 (Print Publication: 2024).
Autor:
Ma HL; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Bizet M; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Soares Da Costa C; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Murisier F; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., de Bony EJ; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Wang MK; CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics and Chinese Academy of Sciences, China National Center for Bioinformation, Beijing 100101, China., Yoshimi A; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Lin KT; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA., Riching KM; Promega Corporation, Madison, WI 53711, USA., Wang X; CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics and Chinese Academy of Sciences, China National Center for Bioinformation, Beijing 100101, China., Beckman JI; Greehey Children's Cancer Research Institute, Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA., Arya S; Greehey Children's Cancer Research Institute, Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA., Droin N; Université Paris-Saclay, INSERM U1287, and Department of Hematology, Gustave Roussy Cancer Center, Villejuif 94800, France., Calonne E; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Hassabi B; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Zhang QY; CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics and Chinese Academy of Sciences, China National Center for Bioinformation, Beijing 100101, China., Li A; CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics and Chinese Academy of Sciences, China National Center for Bioinformation, Beijing 100101, China., Putmans P; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Malbec L; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Hubert C; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Lan J; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Mies F; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Yang Y; CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics and Chinese Academy of Sciences, China National Center for Bioinformation, Beijing 100101, China., Solary E; Université Paris-Saclay, INSERM U1287, and Department of Hematology, Gustave Roussy Cancer Center, Villejuif 94800, France., Daniels DL; Promega Corporation, Madison, WI 53711, USA., Gupta YK; Greehey Children's Cancer Research Institute, Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA., Deplus R; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Abdel-Wahab O; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Yang YG; CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics and Chinese Academy of Sciences, China National Center for Bioinformation, Beijing 100101, China. Electronic address: ygyang@big.ac.cn., Fuks F; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium. Electronic address: francois.fuks@ulb.be.
Publikováno v:
Molecular cell [Mol Cell] 2023 Dec 07; Vol. 83 (23), pp. 4239-4254.e10.
Autor:
Chung FF; International Agency for Research On Cancer (IARC), 25 avenue Tony Garnier, CS 90627, 69366, Lyon, France. feliciacfl@sunway.edu.my.; Department of Medical Sciences, School of Medical and Life Sciences, Sunway University, 5, Jalan Universiti, Bandar Sunway, 47500, Subang Jaya, Selangor, Malaysia. feliciacfl@sunway.edu.my., Maldonado SG; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Nemc A; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Bouaoun L; International Agency for Research On Cancer (IARC), 25 avenue Tony Garnier, CS 90627, 69366, Lyon, France., Cahais V; International Agency for Research On Cancer (IARC), 25 avenue Tony Garnier, CS 90627, 69366, Lyon, France., Cuenin C; International Agency for Research On Cancer (IARC), 25 avenue Tony Garnier, CS 90627, 69366, Lyon, France., Salle A; International Agency for Research On Cancer (IARC), 25 avenue Tony Garnier, CS 90627, 69366, Lyon, France., Johnson T; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Ergüner B; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Laplana M; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany.; Department of Basic Medical Sciences, University of Lleida, IRBLleida, 25198, Lleida, Spain., Datlinger P; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Jeschke J; Laboratory of Cancer Epigenetics, Université Libre de Bruxelles (ULB), Brussels, Belgium., Weiderpass E; International Agency for Research On Cancer (IARC), 25 avenue Tony Garnier, CS 90627, 69366, Lyon, France., Kristensen V; Faculty of Medicine, Institute for Clinical Epidemiology and Molecular Biology, University of Oslo, Oslo, Norway., Delaloge S; Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France., Fuks F; Laboratory of Cancer Epigenetics, Université Libre de Bruxelles (ULB), Brussels, Belgium., Risch A; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany.; Department of Biosciences and Medical Biology, Allergy-Cancer-BioNano Research Centre, University of Salzburg, 5020, Salzburg, Austria.; Cancer Cluster Salzburg, Salzburg, Austria., Ghantous A; International Agency for Research On Cancer (IARC), 25 avenue Tony Garnier, CS 90627, 69366, Lyon, France., Plass C; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany., Bock C; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Medical University of Vienna, Institute of Artificial Intelligence, Center for Medical Data Science, Vienna, Austria., Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Herceg Z; International Agency for Research On Cancer (IARC), 25 avenue Tony Garnier, CS 90627, 69366, Lyon, France. hercegz@iarc.who.int.
Publikováno v:
Clinical epigenetics [Clin Epigenetics] 2023 Jun 12; Vol. 15 (1), pp. 102. Date of Electronic Publication: 2023 Jun 12.
Autor:
Dube G; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Tiamiou A; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium., Bizet M; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Boumahd Y; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium., Gasmi I; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium., Crake R; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium., Bellier J; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium., Nokin MJ; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium., Calonne E; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Deplus R; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Wissocq T; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium., Peulen O; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium., Castronovo V; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium., Fuks F; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium.; WELBIO (Walloon Excellence in Lifesciences & Biotechnology), Brussels, Belgium., Bellahcène A; Metastasis Research Laboratory, GIGA-Cancer, GIGA Institute, University of Liège, Liège, Belgium. a.bellahcene@uliege.be.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Mar 31; Vol. 42 (1), pp. 78. Date of Electronic Publication: 2023 Mar 31.